Theannouncementmarked a departurefromtheTrumpAdministrationstrategyoffholdingback a supplytoensurerequiredseconddosesofthevaccinesareavailable, manufacturingwouldhavetobeconsistentenoughtosupplythoseseconddoseisonschedulethreeorfourweeksafterthefirst, accordingtothe U.